Strategic Partners A/S (CHIX:STRAPc) Stock Price, Trades & News

Strategic Partners A/S enters into strategic partnerships with companies with potential, where the company can take an active ownership and create value through its competencies. Additionally, the company takes part in other equity investments and properties, etc., to generate returns.

Financial Strength

10/10

Name	Current	Vs Industry
Cash-To-Debt	No Debt
Equity-to-Asset	0.94
Interest Coverage	No Debt
Piotroski F-Score	4/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	14.17	Distress Grey Safe
WACC vs ROIC		WACC ROIC

Growth Rank

	Name	Current	Vs Industry		Vs History
	3-Year EBITDA Growth Rate	62.7
	3-Year EPS without NRI Growth Rate	73.3
	3-Year FCF Growth Rate	75.3
	3-Year Book Growth Rate	-27.8

Momentum Rank

10/10

	Name	Current	Vs Industry		Vs History

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	13.9
	Quick Ratio	13.9
	Cash Ratio	13.86

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-5.4

Profitability Rank

	Name	Current	Vs Industry		Vs History
	Operating Margin %	-791.59
	Net Margin %	-277.99
	EBITDA Margin %	-791.59
	FCF Margin %	-691.26
	OCF Margin %	-691.26
	ROE %	-4.63
	ROA %	-4.16
	ROIC %	-68.61
	3-Year ROIIC %	-442.91
	ROCE %	-13.17
	Years of Profitability over Past 10-Year	1

GF Value Rank

	Name	Current	Vs Industry		Vs History
	PS Ratio	76.95
	PB Ratio	1.29
	Price-to-Tangible-Book	1.29
	EV-to-EBIT	-3.45
	EV-to-EBITDA	-3.45
	EV-to-Revenue	27.41
	EV-to-FCF	-3.77
	Price-to-Net-Current-Asset-Value	1.6
	Price-to-Net-Cash	1.61
	Earnings Yield (Greenblatt) %	-28.92
	FCF Yield %	-8.76

GF Value™

CHIX:STRAPc

Warning Signs

Warning! GuruFocus detected 6 Good signs with STRAPc. Try a 7-Day Free Trial to check it out.

Strategic Partners A/S Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Strategic Partners A/S Stock Events

Financials Calendars

Event	Date	Price (kr)
Second quarter earnings results for 2026	2026-08-26	In 60 days
General meeting for 2026	2026-04-28 10:00	8,425.00 (+0.00%)
Annual report for 2025	2026-03-30	8,425.00 (+0.00%)
Second quarter earnings results for 2025	2025-09-16	8,425.00 (+0.00%)
General meeting for 2025	2025-04-29	8,425.00 (+0.00%)
Annual report for 2024	2025-03-31	8,425.00 (+0.00%)
Second quarter earnings results for 2024	2024-08-20	8,425.00 (+0.00%)
0.001:1 Stock Split	2023-12-06	8,425.00 (+0.00%)

Show

Entries

Press Release

	Subject	Date
	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm	2021-09-07
	Final Deadline for Investors with Losses Exceeding $500K to Actively Participate in the Orphazyme A/S (ORPH) Class Action - Bronstein, Gewirtz & Grossman, LLC	2021-09-06
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Orphazyme A/S of Class Action Lawsuit and Upcoming Deadline - ORPH	2021-09-05
	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)	2021-09-03
	ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Orphazyme A/S Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ORPH	2021-08-29
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Orphazyme A/S of Class Action Lawsuit and Upcoming Deadline - ORPH	2021-08-27
	CytRx Highlights Orphazyme's Published Results From Its Phase 2/3 Trial of Arimoclomol in Niemann-Pick Disease Type C	2021-08-24
	ORPH NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Orphazyme A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ORPH	2021-08-17
	Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)	2021-08-13
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Orphazyme A/S of Class Action Lawsuit and Upcoming Deadline - ORPH	2021-08-11

10/Page

Articles on Strategic Partners A/S

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.